PSTX
Price:
$9.5
Market Cap:
$925.93M
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD...[Read more]
Industry
Biotechnology
IPO Date
2020-07-10
Stock Exchange
NASDAQ
Ticker
PSTX
According to Poseida Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.20. This represents a change of 12.21% compared to the average of 2.85 of the last 4 quarters.
The mean historical Current Ratio of Poseida Therapeutics, Inc. over the last ten years is 4.55. The current 3.20 Current Ratio has changed 6.94% with respect to the historical average. Over the past ten years (40 quarters), PSTX's Current Ratio was at its highest in in the September 2020 quarter at 11.67. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
4.55
Median
4.06
Minimum
1.79
Maximum
10.46
Discovering the peaks and valleys of Poseida Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 132.22%
Maximum Annual Current Ratio = 10.46
Minimum Annual Increase = -52.81%
Minimum Annual Current Ratio = 1.79
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 3.18 | -42.69% |
| 2022 | 5.54 | 12.27% |
| 2021 | 4.94 | -52.81% |
| 2020 | 10.46 | 79.71% |
| 2019 | 5.82 | 132.22% |
| 2018 | 2.51 | 14.72% |
| 2017 | 2.18 | 21.89% |
The current Current Ratio of Poseida Therapeutics, Inc. (PSTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.55
5-year avg
5.99
10-year avg
4.55
Poseida Therapeutics, Inc.’s Current Ratio is less than Gracell Biotechnologies Inc. (6.78), greater than Harpoon Therapeutics, Inc. (1.04), less than Albireo Pharma, Inc. (5.93), less than Verve Therapeutics, Inc. (9.84), greater than Intercept Pharmaceuticals, Inc. (2.35), less than Crescent Biopharma, Inc. (6.63), less than Chimerix, Inc. (5.70), less than VectivBio Holding AG (9.14), greater than Avid Bioservices, Inc. (1.30), less than Icosavax, Inc. (16.24),
| Company | Current Ratio | Market cap |
|---|---|---|
| 6.78 | $989.87M | |
| 1.04 | $865.08M | |
| 5.93 | $915.89M | |
| 9.84 | $994.04M | |
| 2.35 | $794.69M | |
| 6.63 | $180.46M | |
| 5.70 | $801.08M | |
| 9.14 | $1.06B | |
| 1.30 | $798.90M | |
| 16.24 | $769.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poseida Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poseida Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Poseida Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Poseida Therapeutics, Inc. (PSTX)?
What is the highest Current Ratio for Poseida Therapeutics, Inc. (PSTX)?
What is the 3-year average Current Ratio for Poseida Therapeutics, Inc. (PSTX)?
What is the 5-year average Current Ratio for Poseida Therapeutics, Inc. (PSTX)?
How does the current Current Ratio for Poseida Therapeutics, Inc. (PSTX) compare to its historical average?